Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.

Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.

Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26.

PMID:
30808827
2.

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation.

Emrich IE, Baier M, Zawada AM, Meyer T, Fliser D, Scharhag J, Heine GH.

Clin Res Cardiol. 2019 Mar;108(3):341-343. doi: 10.1007/s00392-018-1347-7. Epub 2018 Aug 8. No abstract available.

PMID:
30091082
3.

L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis.

Martens-Lobenhoffer J, Emrich IE, Zawada AM, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Amino Acids. 2018 Oct;50(10):1347-1356. doi: 10.1007/s00726-018-2610-y. Epub 2018 Jul 7.

PMID:
29982953
4.

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

Untersteller K, Meissl S, Trieb M, Emrich IE, Zawada AM, Holzer M, Knuplez E, Fliser D, Heine GH, Marsche G.

J Lipid Res. 2018 Jul;59(7):1256-1265. doi: 10.1194/jlr.P085076. Epub 2018 May 22.

5.

Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?

Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH.

Nephrol Dial Transplant. 2019 Jan 1;34(1):100-108. doi: 10.1093/ndt/gfy066.

PMID:
29635392
6.

Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.

Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):569-576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5.

PMID:
29507005
7.

Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.

Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Clin Res Cardiol. 2018 Mar;107(3):201-213. doi: 10.1007/s00392-017-1172-4. Epub 2017 Nov 3.

PMID:
29101459
8.

Reprint of: MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Jun;222(6):831-840. doi: 10.1016/j.imbio.2017.05.003. Epub 2017 May 31.

PMID:
28578934
9.

Erratum.

Emrich IE, Heine GH.

Nephrol Dial Transplant. 2017 Jan 1;32(1):202. doi: 10.1093/ndt/gfw435. No abstract available.

PMID:
28391315
10.

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Bauer L, Kern S, Rogacev KS, Emrich IE, Zawada A, Fliser D, Heinemann A, Heine GH, Marsche G.

J Am Coll Cardiol. 2017 Jan 17;69(2):246-247. doi: 10.1016/j.jacc.2016.10.054. No abstract available.

11.

MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Mar;222(3):587-596. doi: 10.1016/j.imbio.2016.11.006. Epub 2016 Nov 13.

PMID:
27876379
12.

Blood-Pressure and Cholesterol Lowering in the HOPE-3 Trial.

Emrich IE, Schulz DM, Heine GH.

N Engl J Med. 2016 Sep 22;375(12):1190. doi: 10.1056/NEJMc1608916. No abstract available.

PMID:
27653573
13.

Best Albuminuria Measurement to Predict Cardiovascular and Renal Events.

Bauer L, Emrich IE, Pickering JW, Untersteller K, Sandermann F, Rogacev KS, Seiler-Mussler S, Fliser D, Heine GH.

Am J Nephrol. 2016;43(5):383-8. doi: 10.1159/000446483. Epub 2016 May 18.

14.

External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.

Lennartz CS, Pickering JW, Seiler-Mußler S, Bauer L, Untersteller K, Emrich IE, Zawada AM, Radermacher J, Tangri N, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):609-15. doi: 10.2215/CJN.08110715. Epub 2016 Jan 19.

15.

Will too much kidney function kill you: just as none at all?

Emrich IE, Heine GH.

Nephrol Dial Transplant. 2015 Jun;30(6):869-70. doi: 10.1093/ndt/gfv126. No abstract available.

PMID:
25994656
16.

High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.

Bolignano D, Lennartz S, Leonardis D, D'Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C.

Kidney Int. 2015 Jul;88(1):130-6. doi: 10.1038/ki.2015.27. Epub 2015 Feb 18.

PMID:
25692957
17.

Comparison of the performance of 2 GFR estimating equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals.

Emrich IE, Pickering JW, Schöttker B, Lennartz CS, Rogacev KS, Brenner H, Rothenbacher D, Holleczek B, Saum KU, Fliser D, Heine GH.

Am J Kidney Dis. 2015 Apr;65(4):636-8. doi: 10.1053/j.ajkd.2014.12.006. Epub 2015 Jan 23. No abstract available.

PMID:
25620662

Supplemental Content

Loading ...
Support Center